Telo Genomics Corp

3D0A

Company Profile

  • Business description

    Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.

  • Contact

    101 College Street
    Suite 200, MaRS Centre, South Tower
    TorontoONM5G 1L7
    CAN

    T: +1 204 582-0922

    E: [email protected]

    https://www.telodx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    6

Stocks News & Analysis

stocks

Another incredible quarter from Microsoft

We were wrong when we thought last quarter would be hard to top.
stocks

10 best US dividend aristocrats to buy now—including a surprise outperformer

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks

Leading ASX players in this field look materially overvalued

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,999.0016.40-0.18%
CAC 407,878.1016.140.21%
DAX 4024,395.74133.520.55%
Dow JONES (US)44,461.28171.71-0.38%
FTSE 1009,166.4329.490.32%
HKSE24,773.33403.60-1.60%
NASDAQ21,129.6731.380.15%
Nikkei 22541,069.82415.121.02%
NZX 50 Index12,823.7432.23-0.25%
S&P 5006,362.907.96-0.12%
S&P/ASX 2008,742.8013.60-0.16%
SSE Composite Index3,573.2142.51-1.18%

Market Movers